Open-Label Study to Assess the Safety/Tolerability in Patients With Solid Tumors

Clinical trial NCT00820560 · COMPLETED

Trial details

NCT number: NCT00820560
Sponsor: Incyte Corporation
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors and Hematologic Malignancy

Start date: 2005-01-01
Primary completion: 2009-01-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.